These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 25905480)

  • 1. Pharmacovigilance in India, Uganda and South Africa with reference to WHO's minimum requirements.
    Maigetter K; Pollock AM; Kadam A; Ward K; Weiss MG
    Int J Health Policy Manag; 2015 Mar; 4(5):295-305. PubMed ID: 25905480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.
    Jusot V; Chimimba F; Dzabala N; Menang O; Cole J; Gardiner G; Ofori-Anyinam O; Oladehin O; Sambakunsi C; Kawaye M; Stegmann JU; Guerra Mendoza Y
    Drug Saf; 2020 Jun; 43(6):583-593. PubMed ID: 32239447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries.
    Isah AO; Opadeyi AO; Tumwijukye H; Cobelens F; Smith D; Ndomondo-Sigonda M; Harmark L; Tanui P; Tiemersma E; Mmbaga BT; Mahlangu G; Ayinbuomwan SA; Soulaymani R; Pandit JM
    Ther Adv Drug Saf; 2023; 14():20420986231188836. PubMed ID: 37529763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacovigilance in resource-limited countries.
    Olsson S; Pal SN; Dodoo A
    Expert Rev Clin Pharmacol; 2015; 8(4):449-60. PubMed ID: 26041035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacovigilance in the Caribbean Countries: an Overview.
    Walker KEW; Bankay R; Jankie S; Dhingra S
    Curr Pharmacol Rep; 2023 May; ():1-11. PubMed ID: 37360536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety reporting through a comprehensive and pragmatic pharmcovigilance process for India and emerging markets: an industry perspective.
    Swamy S; Mourya M; Kadhe G; Mane A; Sawant S
    Expert Opin Drug Saf; 2015; 14(9):1409-20. PubMed ID: 26292785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacovigilance in India in Comparison With the USA and European Union: Challenges and Perspectives.
    Jose J; Rafeek NR
    Ther Innov Regul Sci; 2019 Nov; 53(6):781-786. PubMed ID: 30554527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review.
    Makhene NL; Steyn H; Vorster M; Lubbe MS; Burger JR
    Ther Adv Drug Saf; 2023; 14():20420986221143272. PubMed ID: 36713000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the Current State of Pharmacovigilance System in Pakistan Using Indicator-Based Assessment Tool.
    Khan MAA; Hamid S; Ur-Rehman T; Babar ZU
    Front Pharmacol; 2021; 12():789103. PubMed ID: 35095498
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacovigilance activities in ASEAN countries.
    Suwankesawong W; Dhippayom T; Tan-Koi WC; Kongkaew C
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1061-9. PubMed ID: 27174034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pacific Island Pharmacovigilance: The Need for a Different Approach.
    McEwen J; Vestergaard LS; Sanburg AL
    Drug Saf; 2016 Oct; 39(10):891-4. PubMed ID: 27364632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capacity for a global vaccine safety system: the perspective of national regulatory authorities.
    Graham JE; Borda-Rodriguez A; Huzair F; Zinck E
    Vaccine; 2012 Jul; 30(33):4953-9. PubMed ID: 22658930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania.
    Barry A; Olsson S; Minzi O; Bienvenu E; Makonnen E; Kamuhabwa A; Oluka M; Guantai A; Bergman U; van Puijenbroek E; Gurumurthy P; Aklillu E
    Drug Saf; 2020 Apr; 43(4):339-350. PubMed ID: 31919794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The right to health as the basis for universal health coverage: A cross-national analysis of national medicines policies of 71 countries.
    Perehudoff SK; Alexandrov NV; Hogerzeil HV
    PLoS One; 2019; 14(6):e0215577. PubMed ID: 31251737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. World Bank credits Uganda with $50m. -- emphasis on communities, NGOs and health.
    AIDS Anal Afr; 1994; 4(3):1-2. PubMed ID: 12318855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse event reporting tools and regulatory measures in India through outcome of Pharmacovigilance Programme of India.
    Prakash J; Sachdeva R; Shrivastava TP; Jayachandran CV; Sahu A
    Indian J Pharmacol; 2021; 53(2):143-152. PubMed ID: 34100398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
    Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
    Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National pharmacovigilance programs in Arab countries: A quantitative assessment study.
    Alshammari TM; Alenzi KA; Ata SI
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1001-1010. PubMed ID: 32181540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacovigilance of herbal medicines: Concerns and future prospects.
    Choudhury A; Singh PA; Bajwa N; Dash S; Bisht P
    J Ethnopharmacol; 2023 Jun; 309():116383. PubMed ID: 36918049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic monoclonal antibodies and the need for targeted pharmacovigilance in India.
    Kalaivani M; Singh A; Kalaiselvan V
    MAbs; 2015; 7(1):276-80. PubMed ID: 25523367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.